- Home
- STRO vs FLL Comparison
STRO vs FLL Comparison
Compare STRO & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | FLL |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 108.7M |
| IPO Year | 2018 | 1993 |
Fundamental Metrics
Financial Performance| Metric | STRO | FLL |
|---|---|---|
| Price | $9.03 | $3.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $19.67 | $5.00 |
| AVG Volume (30 Days) | 112.9K | ★ 172.8K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $105,646,000.00 | ★ $299,916,000.00 |
| Revenue This Year | $62.61 | $4.94 |
| Revenue Next Year | N/A | $7.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $5.23 | $2.25 |
| 52 Week High | $21.50 | $5.59 |
Technical Indicators
Market Signals| Indicator | STRO | FLL |
|---|---|---|
| Relative Strength Index (RSI) | 77.00 | 61.72 |
| Support Level | $9.53 | $2.86 |
| Resistance Level | $10.10 | $3.25 |
| Average True Range (ATR) | 0.78 | 0.19 |
| MACD | 0.36 | 0.04 |
| Stochastic Oscillator | 89.12 | 67.97 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.